Skip to content

Avalon Investment & Advisory: ITOT position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Avalon Investment & Advisory on ITOT, newest first. How the timeline and the estimate are built.

Avalon Investment & Advisory held 30,133 ITOT shares at 2023-03-31 per its 13F-HR filed 2023-05-15.

the latest 13F is the newest step

  1. period ended2023-03-31
    13F 30,133 shares
    Change vs previous 13F +324 shares

    0.07% of the 13F portfolio, value $2,728,541.

    13F-HR 0001221362-23-000004 filed by Avalon Investment & Advisory
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-12-31
    13F 29,809 shares
    Change vs previous 13F -2,339 shares

    0.07% of the 13F portfolio, value $2,528,000.

    13F-HR 0001221362-23-000002 filed by Avalon Investment & Advisory
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2022-09-30
    13F 32,148 shares
    Change vs previous 13F +1,628 shares

    0.08% of the 13F portfolio, value $2,557,000.

    13F-HR 0001221362-22-000004 filed by Avalon Investment & Advisory
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2022-06-30
    13F 30,520 shares
    Change vs previous 13F 0 shares

    0.07% of the 13F portfolio, value $2,557,000.

    13F-HR 0001221362-22-000003 filed by Avalon Investment & Advisory
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2022-03-31
    13F 30,520 shares
    Change vs previous 13F not available

    0.07% of the 13F portfolio, value $3,081,000.

    13F-HR 0001221362-22-000002 filed by Avalon Investment & Advisory
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).